Literature DB >> 18787279

Evaluation of bone mineral density among patients with inflammatory bowel disease in a tertiary care setting in India.

Rajesh Khadgawat1, Govind K Makharia, Kanika Puri.   

Abstract

BACKGROUND: Patients with inflammatory bowel disease (IBD) have low bone mineral density (BMD). Dietary calcium is important for them in the prevention of osteopenia and osteoporosis. There are no reports on the status of BMD in Indian patients with IBD.
METHODS: Dietary calcium intake and cumulative steroid and immunosuppressive drug use was noted in 46 randomly selected patients (mean [SD] age 40.5 [14.7] years; 28 men) with IBD (ulcerative colitis 22, Crohn's disease 24). To compare values of BMD for patients, data from 46 age- and sex-matched healthy controls (age 40.5 [14.6] years; 28 men) were selected from an existing database of healthy Indian volunteers whose BMD had been measured in a community-based survey carried out among people residing in Delhi (unpublished data). BMD was measured using DXA (Hologic QDR 4500). Osteopenia and osteoporosis were defined as per the standard WHO criteria.
RESULTS: The mean duration of disease was 87.7 (78.3) months. The mean calcium intake by 41 patients (89.1%) was <200 mg/day, by 2 patients (4.3%) 200-400 mg/day and by 3 patients (6.4%)>400 mg/day. Significantly lower values of BMD at the spine and hip regions were seen in patients with both ulcerative colitis and Crohn's disease as compared with Indian healthy controls. In comparison to age- and sex-matched healthy controls, 29 (63%) and 21 (45.6%) patients had either osteopenia or osteoporosis at the spine and hip region, respectively. Of them, 4 and 7 patients had osteoporosis at the spine and hip region, respectively. There was no correlation between values of BMD and the age of patient, duration of disease, and cumulative steroid dose.
CONCLUSIONS: Two thirds of Indian patients with IBD have low BMD. Since the intake of dietary calcium is inadequate in a majority of these patients, they should be advised to increase the intake of dairy products.

Entities:  

Mesh:

Year:  2008        PMID: 18787279

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  13 in total

1.  Bone density in pediatric Crohn's disease: A cross-sectional observation from South India.

Authors:  Shiraz Salim Khan; Sagar S Patil
Journal:  Indian J Gastroenterol       Date:  2017-06-20

2.  Indian Society of Gastroenterology consensus statements on Crohn's disease in India.

Authors:  Balakrishnan S Ramakrishna; Govind K Makharia; Vineet Ahuja; Uday C Ghoshal; Venkataraman Jayanthi; Benjamin Perakath; Philip Abraham; Deepak K Bhasin; Shobna J Bhatia; Gourdas Choudhuri; Sunil Dadhich; Devendra Desai; Bhaba Dev Goswami; Sanjeev K Issar; Ajay K Jain; Rakesh Kochhar; Goundappa Loganathan; Sri Prakash Misra; C Ganesh Pai; Sujoy Pal; Mathew Philip; Anna Pulimood; Amarender S Puri; Gautam Ray; Shivaram P Singh; Ajit Sood; Venkatraman Subramanian
Journal:  Indian J Gastroenterol       Date:  2015-03-14

3.  Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients.

Authors:  Bincy P Abraham; Preethi Prasad; Hoda M Malaty
Journal:  Dig Dis Sci       Date:  2014-03-12       Impact factor: 3.199

4.  Vitamin D deficiency in adult patients with ulcerative colitis: Prevalence and relationship with disease severity, extent, and duration.

Authors:  Arjun Datt Law; Usha Dutta; Rakesh Kochhar; Chetana Vaishnavi; Shiva Kumar; Talha Noor; Sanjay Bhadada; Kartar Singh
Journal:  Indian J Gastroenterol       Date:  2019-03-13

5.  Prevalence and risk factors for low bone mineral density in ulcerative colitis.

Authors:  Ram Pratap Singh Bundela; Prachis Ashdhir; Kumar Shwetanshu Narayan; Mukesh Jain; Rupesh Kumar Pokharna; Sandeep Nijhawan
Journal:  Indian J Gastroenterol       Date:  2017-06-23

6.  Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis.

Authors:  P Szafors; H Che; T Barnetche; J Morel; C Gaujoux-Viala; B Combe; C Lukas
Journal:  Osteoporos Int       Date:  2018-06-16       Impact factor: 4.507

7.  Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients.

Authors:  Debottam Bandyopadhyay; Sanjay Bandyopadhyay; Parasar Ghosh; Abhishek De; Anupam Bhattacharya; G K Dhali; Kshaunish Das
Journal:  Indian J Gastroenterol       Date:  2015-11-28

8.  A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression.

Authors:  Kathleen A Bishop; Mark B Meyer; J Wesley Pike
Journal:  Mol Endocrinol       Date:  2009-10-30

Review 9.  The impact of inflammation on bone mass in children.

Authors:  Wai W Cheung; Jian-Ying Zhan; Kyung Hoon Paik; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2011-01-01       Impact factor: 3.714

10.  Indian Society of Gastroenterology consensus on ulcerative colitis.

Authors:  Balakrishnan S Ramakrishna; Govind K Makharia; Philip Abraham; Uday C Ghoshal; Venkataraman Jayanthi; Brij Kishore Agarwal; Vineet Ahuja; Deepak K Bhasin; Shobna J Bhatia; Gourdas Choudhuri; Sunil Dadhich; Devendra C Desai; Gopal Krishna Dhali; Bhaba Dev Goswami; Sanjeev K Issar; Ajay K Jain; Rakesh Kochhar; Ajay Kumar; Goundappa Loganathan; Sri Prakash Misra; C Ganesh Pai; Sujoy Pal; Anna Pulimood; Amarender S Puri; Ganesh N Ramesh; Gautam Ray; Shivaram P Singh; Ajit Sood; Manu Tandan
Journal:  Indian J Gastroenterol       Date:  2012-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.